Ipamorelin 5mg

Ipamorelin 5mg

£0.00
£15.95

View Product Information

Quantity

Earn 0 reward points

We’re sorry we’re out of stock, but we can let you know as soon as this product becomes available again.

Enter your details below and we’ll email you once this item is back in stock.

Your NameYour Email Address

Ipamorelin

EACH VIAL CONTAINS 5MG OF IPAMORELIN


Supplied for Research Purposes Only

This information and product is provided for research purposes only. We do not provide any advice on the usage of these products as UK Law prevents this. Customers should check the legality of this product in their own country prior to purchase.


Benefits and uses:

Leaner muscle mass, increased collagen production, and decreased body fat.

Increased cellular repair and regeneration due to better sleep.

IGF-1 elevation raises bone mineral content.

Counteracts the catabolic effects of glucocorticoids.

Lessens hunger stimulation compared to GHRP-6.

Reduced cortisol, prolactin, and aldosterone release.


Dose:

300mcg, 3 times daily for strength gain and performance enhancement

200mcg, 1 time daily for anti-aging purposes


WHAT IS IT IPAMORELIN ?

One of the most cutting-edge peptides in the growth factor family is ipamorelin. Ipamorelin, a selective growth hormone (GH) secretagogue and ghrelin receptor agonist, is one of the safest GHRPs.

This peptide causes growth hormone secretion to rise similarly to other members of its class, but without increasing cortisol, acetylcholine, prolactin, or aldosterone or stimulating appetite.

In human clinical investigations, ipamorelin has proven to be highly effective and to have good safety and tolerability.

According to research, ipamorelin is specialised for growth hormone, hence the hormones produced by the pituitary are (such as cortisol are unaffected).

One of the best HGH therapy substitutes might be ipamorelin.

Additionally, it does not encourage increased ghrelin production, which increases appetite. As a result of ipamorelin's capacity to regulate points of stomach, appetite, and growth motility, it won't make you hungry.

Ipamorelin does not exhibit a capability to considerably elevate cortisol levels, which might have unfavourable effects on the body. This is another important good difference. Because of the therapy's overall effect on cortisol levels, patients receiving various secretagogue medications have complained of jitters, cold sweats, or anxiousness.


CJC-1295 / Ipamorelin: What is it?

Together, CJC-1295 and ipamorelin activate the pituitary for optimal growth hormone synthesis. More receptors are engaged when CJC-1295 and ipamorelin are combined, which boosts the production of growth hormones. Add IGF-1 to this combination, which is currently the second-best product on the market.


Does ipamorelin make you gain weight?

No. Ipamorelin does not increase harmful hormones like cortisol (responsible for stress and muscle loss), prolactin (responsible for sexual side effects and water retention), or ghrelin (responsible for hunger) compared to GHRP-6 and GHRP-2. It is used to help people lose weight, build muscle, and delay the ageing process.


What distinguishes Sermorelin from Ipamorelin?

Ipamorelin, like sermorelin, aids in promoting the generation of natural growth hormone. Because it promotes IGF-1 production in the liver without relying on GH levels, ipamorelin is exceptional. This indicates that ipamorelin can more effectively stimulate the body's systems involved in growth and repair.


Reference: 

Gobburu JV, Agersø H, Jusko WJ, Ynddal L (September 1999). "Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers". Pharmaceutical Research. 16 (9): 1412–6. doi:10.1023/A:1018955126402. PMID 10496658. S2CID 12048934.

 Moulin A, Ryan J, Martinez J, Fehrentz JA (September 2007). "Recent developments in ghrelin receptor ligands". ChemMedChem. 2 (9): 1242–59. doi:10.1002/cmdc.200700015. PMID 17520591. S2CID 24945528.

 Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH (November 1998). "Ipamorelin, the first selective growth hormone secretagogue". European Journal of Endocrinology. 139 (5): 552–61. doi:10.1530/eje.0.1390552. PMID 9849822.

 Isidro ML, Cordido F (March 2006). "Growth hormone secretagogues". Combinatorial Chemistry & High Throughput Screening. 9 (3): 175–80. doi:10.2174/138620706776055458. PMID 16533150.

 Jiménez-Reina L, Cañete R, De la Torre MJ, Bernal G (2002). "Chronic In Vivo Ipamorelin Treatment Stimulates Body Weight Gain and Growth Hormone (GH) Release In Vitro in Young Female Rats". European Journal of Anatomy. 6 (1): 37–46. ISSN 1136-4890.

 Beck DE, Sweeney WB, McCarter MD (December 2014). "Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients". International Journal of Colorectal Disease. 29 (12): 1527–34. doi:10.1007/s00384-014-2030-8. PMID 25331030. S2CID 22869695.

 "Ipamorelin". AdisInsight. Springer Nature Switzerland AG. Retrieved 10 June 2015.

 Perez AJ (5 May 2016). "Peptides under greater scrutiny in MLB's performance-enhancing drug battle". USA TODAY. Retrieved 2018-04-14.

 Maloney J (13 April 2018). "NBA Playoffs 2018: Wizards' Jodie Meeks suspended 25 games for failing drug test". CBSSports.com. Retrieved 2018-04-14.

 "Nets' Chandler suspended 25 games for PED use". nba.com. Retrieved 2019-08-30.

Be the first to review this product.

Leave a review